These findings introduced a new category of “High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements” to the World Health Organization 2017 Classification of Tumors of Hematopoietic and Lymphoid Tissues [5]. Here, BCL2 is linked to B-cell non-Hodgkin lymphoma.